Information Library

Results for: Market analysis

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Oncology Experience

    Brochure — February 7, 2012
    Quintiles acquires Outcome to offer full spectrum of inventional and observational research. Together, we offer the expertise and experience in real-world and late phase research

  • Reinventing Biopharma

    White Paper — February 1, 2012
    The biopharmaceutical industry today is facing a multifaceted “value challenge.”

  • Re-ignite Product Development and Sales with Data Insights: Fueling Innovation Fact Sheet

    Brochure — November 17, 2011
    What Will Drive Biopharma’s Future? The long-dreaded crisis is staring us all in the face: What will take the place of expiring blockbusters with few prospects in hand? Spending on R&D more than doubled after 2002, but the output doesn’t match the investment. The number of new molecular entities has remained a disappointment, averaging only around 20 per year in the US. The big question is how can drug developers carve out a strategic path to innovation?

  • Market Intelligence - When There's No Room for Error Fact Sheet

    Brochure — November 17, 2011
    In the world of biopharmaceutical development, market researchers are in the hot seat. Crucial decisions hinge on research results more than ever, and each decision must be made even faster to have real impact.

  • Vaccine Insights

    Presentation — April 19, 2011
    Quintiles’ Jason Baumgartner, Life Sciences Consulting Director, presented on “Understanding Socio-Economic Drivers to Increase Vaccination Coverage” at the World Vaccine Congress 2011

  • New Healthcare Architecture to Maximize Vaccine Coverage Rates

    Hear from the Experts — April 19, 2011
    Jason Baumgartner discusses the steps required to create a complete healthcare architecture the shift among biopharma toward preventive medicine.

  • Improved Commercialization Strategy through Stakeholder Network Mapping

    Case Study — February 7, 2011
    Understanding the KOL and physicians influencer landscape is a mission critical component of a bio-pharma product’s market access strategy and commercialization plan. Influencer network mapping

  • Proven Precision

    Brochure — February 2, 2011
    Quintiles brings together – under a dedicated project manager – incredibly talented regulatory strategists, medical writers, biostatisticians, and medical, publishing and clinical pharmacology specialists who work closely together to design and implement efficient, effective submissions from beginning to end.

  • Podcast: Market Segmentation

    Hear from the Experts — January 27, 2011
    Ismael Carreras, Ph.D., senior research director, market intelligence at Quintiles, details some new approaches to market segmentation for the biopharmaceutical industry.

  • Probabilistically Forecasting Long-term Market Landscapes via Bayesian Networks

    Presentation — October 10, 2010
    As Strategic business decisions must often be based on long-range projections under considerable uncertainty, the presenation demonstrates how Byesian networks provide a coherent framework for

Page 1 of 3 (28 results)

Subscribe to Email Based on Your Interests

Set preferences